Lentivirus vectors are one of the most widely used tools in molecular biology and gene therapy due to their ability to integrate into the host genome and express foreign genes over an extended period of time. They belong to a family of retroviruses, specifically the lentivirus genus, which includes the human immunodeficiency virus (HIV). Lentiviruses are unique in that they can infect both dividing and non-dividing cells, making them invaluable in gene therapy applications and the production of transgenic animals.

Lentiviruses are enveloped viruses with a single-stranded RNA genome. Upon infection, the RNA genome is reverse-transcribed into DNA and integrated into the host cell's genome by the viral integrase enzyme. This process of integration ensures stable, long-term expression of the foreign gene introduced via the viral vector.

Lentivirus Vectors: An Overview
Lentivirus Vectors: An Overview

The lentivirus vector are engineered versions of these viruses, modified to remove the viral genes responsible for pathogenicity, while retaining the ability to deliver genetic material into host cells. The packaging system for lentiviral vectors typically includes two components: one expressing the viral proteins necessary for virion production and another containing the genetic material to be delivered.

Lentiviral vectors offer several advantages over other viral and non-viral delivery systems:

Lentiviral vectors have a broad spectrum of applications in research, gene therapy, and biotechnology:

While lentiviral vectors have many benefits, there are some challenges and safety considerations:

Lentiviral vector technology continues to evolve. Current research is focused on improving the safety and efficiency of these vectors:

 


Daniel Harper

2 posts

Related post